| Item | Cat. No. | Application | Isotype | 
| Anti-Cry1 mAbs [3H9](MABL-1276) | MABL-1276 | ELISA | Engineer antibody | 
| Anti-Cryptosporidium mAbs [B-G2.7](MABL-1277) | MABL-1277 | ELISA, IF | Engineer antibody | 
| Anti-CTGF mAbs [HL2180 [17-73-D6]](MABL-1278) | MABL-1278 | WB, ELISA, IHC | Engineer antibody | 
| Anti-CTGF mAbs [HL2181](MABL-1279) | MABL-1279 | WB, ELISA | Engineer antibody | 
| Anti-CTGF mAbs [HL2198](MABL-1280) | MABL-1280 | ELISA | Engineer antibody | 
| Anti-CTLA-4 mAbs [11.2.1](MABL-1281) | MABL-1281 | in vivo | Engineer antibody | 
| Anti-CTLA-4 mAbs [4.1.1](MABL-1282) | MABL-1282 | ELISA | Engineer antibody | 
| Anti-CTLA-4 mAbs [4.13.1](MABL-1283) | MABL-1283 | Engineer antibody | |
| Anti-CTLA-4 mAbs [4.8.1](MABL-1284) | MABL-1284 | ELISA | Engineer antibody | 
| Anti-CTLA-4 mAbs [5E 3](MABL-1285) | MABL-1285 | in vivo, ELISA | Engineer antibody | 
| Anti-CTLA-4 mAbs [9D9](MABL-1286) | MABL-1286 | Block, IF | Engineer antibody | 
| Anti-CTLA-4 mAbs [9H10](MABL-1287) | MABL-1287 | Neutralisation, proliferation assays, WB, ELISA, FC | Engineer antibody | 
| Anti-CTLA-4 mAbs [CP-675,206 (Tremelimumab, 11.2.1)](MABL-1288) | MABL-1288 | FC, Block, ELISA | Engineer antibody | 
| Anti-CTLA-4 mAbs [N-1](MABL-1289) | MABL-1289 | ELISA | Engineer antibody | 
| Anti-CTLA-4 mAbs [NB25B-17](MABL-1290) | MABL-1290 | FACS, in vivo | Engineer antibody | 
| Anti-CTLA4 mAbs [1B8](MABL-1291) | MABL-1291 | Blocking, WB, ELISA, FC, IF | Engineer antibody | 
| Anti-CTLA4 mAbs [Ab001CTLA4](MABL-1292) | MABL-1292 | WB, ELISA | Engineer antibody | 
| Anti-CTLA4 mAbs [Ab002CTLA4](MABL-1293) | MABL-1293 | WB, ELISA | Engineer antibody | 
| Anti-CTLA4 mAbs [H11](MABL-1294) | MABL-1294 | functional assays, FC, IF | Engineer antibody | 
| Anti-cTnI mAbs [MG4](MABL-1295) | MABL-1295 | ELISA | Engineer antibody | 
 
      联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
